Skip to main content
Equibles
RVMD logo

RVMD · Revolution Medicines, Inc.

Track RVMD — free

Use RVMD with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about RVMD

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$203.71 +1.71 (+0.85%) At close · Aug 14
Market Cap
$43.66B
Shares
214.34M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$203.71 Open$201.50 Day$198.89–204.00 52W close$35.67–206.97 Avg vol 30d1.8M Short int11.5M · 5.4% float · 6.3d Short vol60% Last earningsAug 5, 2026 DataFeb 2020–Aug 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 11 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 5, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Buy
      SellHoldBuy
      Technical Strong Buy Momentum Very Strong Sentiment Bullish Fundamentals Weak Quant / Vol High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Strong Buy
      50 / 200-day cross No cross
      Price vs 200-day avg +66%
      above
      Price vs 50-day avg +13%
      above
      RSI (14) 63
      neutral
      MACD trend Positive
      52-week position 98%
      near high
      Momentum
      relative strength
      Very Strong
      1-month return +9%
      trailing
      6-month return +96%
      trailing
      YTD return +156%
      this year
      Relative strength +83%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bullish
      Trend (MA cross) No cross
      50d $181 › 200d $123 — 50d above 200d
      Institutional flow Accumulating
      +31% holders QoQ · +240 funds added
      Insider flow Distributing
      Net -$720.5K over 90 days · 100% sells
      Short interest Falling
      5.37% of float · ▼ -17.7% MoM · 6.3 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      687 holders — near 3-yr high, broad support
      Squeeze score 69
      elevated · 0–100
      Fundamentals
      Weak
      EPS growth −66%
      Y/Y
      Free cash flow $-913.7M
      Balance sheet $383.7M
      net cash
      Quant / Vol
      risk profile
      High
      Volatility 68%
      annualized · 1-yr
      Max drawdown −25%
      past year
      ATR 3.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed May 6, 2026
      GAAP operating expenses · full year 2026 GAAP $1.7B – $1.8B
      Prior guidance period ended · from the 8-K filed Nov 5, 2025
      Non-cash stock-based compensation expense · full year 2025 $115M – $130M

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Buy
      0 · 2 · 4
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      +66% Bullish
      Price vs 50-day avg
      +13% Bullish
      RSI (14)
      63 Neutral
      MACD trend
      Positive Bullish
      52-week position
      98% Bullish
      Market signals — smart money & positioning
      Bullish · 3 of 6
      Trend (MA cross) No cross
      50d $181 › 200d $123 — 50d above 200d
      Institutional flow Accumulating
      +31% holders QoQ · +240 funds added
      Insider flow Distributing
      Net -$720.5K over 90 days · 100% sells
      Short interest Falling
      5.37% of float · ▼ -17.7% MoM · 6.3 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      687 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $36 Now $204 · 98% Range high $207
      vs 200-day avg +66% vs 50-day avg +13%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Versus peers

      Biotechnology — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      RVMD
      Revolution Medicines, Inc.
      this stock
      		$43.66B +155.8% — — 5.4%
      ONC
      BeOne Medicines Ltd.
      		 $513.62B +14.4% +22179.2% 789.7 0.1%
      VRTX
      Vertex Pharmaceuticals Inc / Ma
      		 $128.19B +11.6% +46.2% 29.5 1.6%
      REGN
      Regeneron Pharmaceuticals, Inc.
      		 $82.72B +4.1% +20.8% 19.9 3.3%
      ARGX
      Argenx SE
      		 $52.94B +1.2% — — 2.1%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      687
      % held
      106.5%
      Net QoQ
      +11.8M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      462
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      11.5M
      Days to cover
      6.3d
      Change
      -2.5M sh
      View
      Short Volume
      Short vol %
      60%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      778
      Value
      $147.2K
      As of
      Jul 6, 2026
      View
      Off-Exchange
      Off-exchange %
      44.4%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$720.5K
      Buyers / Sellers
      0 / 1
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $0
      Net income (FY)
      $-1.1B
      EPS diluted
      $-5.95
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 5, 2026
      This year
      12
      View
      Proposed Sales
      Value
      $1.0M
      Shares
      5.6K
      Filed
      Jun 29, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 5, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      RVMD -0.7% +9.4% +96.5% +8.6% +155.8%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -1.1% +5.0% +82.7% +4.7% +141.9%
      Key facts CIK 1628171 CUSIP 76155X100 13F (30d) 642 filings 634 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)